CALR and essential thrombocythemia: The diagnostic value of CALR mutation confirmation has been defined only recently by including CALR mutations in the diagnostic criteria for ET/PMF in the 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukaemia11.